Known targets — ChEMBL curated mechanism
ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL24132 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL28580751 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL28093047 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL30760667 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL29661854 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL23415272 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL16180766 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL409772 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL4624626 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL2030434 | 0.98 | LMNA (0.95) | LMNAPDE4AL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111269978-B | Human ApoE genotyping detection kit | 深圳市天大生物医疗器械有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-111269978-A | Human ApoE genotyping detection kit | 深圳市天大生物医疗器械有限公司 | 2020-06-12 | — | — | CN | claimed |
| CN-108936689-A | Adjust the oral solution and preparation method thereof of immunity | 江西皓宇生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108289860-A | Preparation for sticking to tooth or tooth periphery | 株式会社 LG 生活健康 | 2018-07-17 | — | — | CN | claimed |
| CN-103479652-B | Children's four-vitamin calcium gluconate effervescent tablets and preparation method thereof | FUZHOU NEPTUNUS FUYAO PHARMACEUTICAL CO LTD | 2014-12-03 | — | — | CN | claimed |
| CN-103479652-A | Children's four-vitamin calcium gluconate effervescent tablets and preparation method thereof | FUZHOU NEPTUNUS FUYAO PHARMACEUTICAL CO LTD | 2014-01-01 | — | — | CN | claimed |
| CN-101869302-B | Micro-emulsion calcium preparation and preparation method as well as application thereof | NIU XIN | 2013-01-30 | — | — | CN | claimed |
| US-20260115122-A1 | PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM | Galderma Holding SA (CH) | 2026-04-30 | — | — | US | disclosed |
| EP-4547340-A1 | PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM | Galderma Holding SA (CH) | 2025-05-07 | — | — | EP | disclosed |
| US-20250032388-A1 | PERSONAL CARE COMPOSITIONS FOR SENSITIVE SKIN AND METHODS OF USE | Galderma Holding SA (CH) | 2025-01-30 | — | — | US | disclosed |
| WO-2024003594-A1 | PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM | Galderma Holding SA (CH) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023192538-A1 | PERSONAL CARE COMPOSITIONS FOR SENSITIVE SKIN AND METHODS OF USE | Galderma Holding SA (CH) | 2023-10-05 | — | — | WO | disclosed |
| CN-116209419-A | Hair composition, auxiliary agent composition, and hair treatment method | 株式会社玫丽盼 | 2023-06-02 | — | — | CN | disclosed |
| CN-101574334-A | Method for preparing calcium gluconate preparation | HARBIN PHARMACEUTICAL GROUP SA (CN) | 2009-11-11 | — | — | CN | disclosed |
| CN-101485824-A | Chinese medicament preparation for tonifying kidney and benefiting brain as well as preparation method and novel use thereof | BEIJING ASIA EAST BIO PHARM CO (CN) | 2009-07-22 | — | — | CN | disclosed |
| CN-1957908-A | Method for preparing gel of zinc calcium gluconate | ZHONGJI PHARMACEUTICAL CO LTD (CN) | 2007-05-09 | — | — | CN | disclosed |
| CN-1927196-A | Preparing process for freeze-dried calcium gluconate powder injection | ZHANG WEIQUN (CN) | 2007-03-14 | — | — | CN | disclosed |
| CN-1857229-A | Medicine dragee suitable for children to take and its preparing method | MAO XIAOMIN (CN) | 2006-11-08 | — | — | CN | disclosed |
| CN-1830460-A | Xuesaitong (thrombus clearout) chewing tablet and its preparation method | TAN ANDE (CN) | 2006-09-13 | — | — | CN | disclosed |
| CN-1799541-A | Soybean isoflavone soft capsule and its preparation process | TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CO LTD (CN) | 2006-07-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115122-A1 | PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM | B3GNT2, GLA, AMPD2 | LMNA 2668/4885PDE4A 989/4885L3MBTL1 2895/4885 |
| US-20250032388-A1 | PERSONAL CARE COMPOSITIONS FOR SENSITIVE SKIN AND METHODS OF USE | GLA, CUTA, COLGALT1 | LMNA 104/4885PDE4A 2503/4885L3MBTL1 1918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.